Javelin Pharmaceuticals Inc (JAV)

[Bio_pete]

NERF, I don't think we're going to see a pop and then a drift lower as investors take profits. This is huge news. We've gone from a biotech to a pharmaceutical company with rapidly growing sales in the next few yrs. JAV has the pre-NDA meeting for nasal ketamine in a few weeks which is a going to garner alot of attention. Anything less then $6 looks like a bargain now that UK approval is a done deal.